AbCellera Biologics Inc.

ABCL | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.66

+$0.03 (+0.24%)

At close: Sep 21, 2026, 4:00 PM ET

$12.70

+$0.04 (+0.32%)

Pre-market: Sep 22, 2026, 8:14 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	75.13M	28.83M	38.03M	485.42M	375.2M	233.16M
Cost of Revenue	28.82M	n/a	n/a	66.44M	45.52M	27.14M
Gross Profit	46.31M	28.83M	38.03M	418.99M	329.69M	206.01M
Operating Income	-217.1M	-314.77M	-237.21M	216.51M	204.41M	156.03M
Interest Income	28.33M	38.47M	42.25M	16.08M	3.33M	293K
Pretax Income	-177.6M	-200.4M	-174.03M	239.1M	219.15M	157.83M
Net Income	-146.41M	-162.86M	-146.4M	158.52M	153.46M	118.92M
Selling & General & Admin	76.58M	85.49M	75.18M	66.76M	48.76M	15.75M
Research & Development	186.83M	167.26M	175.66M	107.88M	62.06M	29.39M
Other Expenses	n/a	90.85M	24.4M	27.84M	14.45M	4.84M
Operating Expenses	263.41M	343.6M	275.23M	202.48M	125.27M	49.98M
Interest Expense	n/a	n/a	n/a	4.05M	5.23M	6.51M
Selling & Marketing Expenses	n/a	12.78M	14.18M	11.27M	6.91M	3.84M
Cost & Expenses	292.23M	343.6M	275.23M	268.91M	170.79M	77.12M
Income Tax Expense	-31.18M	-37.54M	-27.63M	80.58M	65.69M	38.92M
Shares Outstanding (Basic)	298.71M	294.33M	289.17M	285.06M	275.76M	263.13M
Shares Outstanding (Diluted)	298.71M	294.33M	289.17M	314.83M	318.29M	263.13M
EPS (Basic)	-0.49	-0.55	-0.51	0.56	0.56	0.45
EPS (Diluted)	-0.49	-0.55	-0.51	0.50	0.48	0.45
EBITDA	-148.77M	-204.15M	-192.16M	260.17M	239.15M	169.62M
EBIT	-177.6M	-301.15M	-223.05M	227.07M	221.9M	164.34M
Depreciation & Amortization	28.82M	97M	30.89M	33.1M	17.25M	5.27M